Cite
Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation.
MLA
Ciccosanti, Fabiola, et al. “Proteomic Analysis Identifies a Signature of Disease Severity in the Plasma of COVID-19 Pneumonia Patients Associated to Neutrophil, Platelet and Complement Activation.” Clinical Proteomics, vol. 19, no. 1, Nov. 2022, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s12014-022-09377-7.
APA
Ciccosanti, F., Antonioli, M., Sacchi, A., Notari, S., Farina, A., Beccacece, A., Fusto, M., Vergori, A., D’Offizi, G., Taglietti, F., Antinori, A., Nicastri, E., Marchioni, L., Palmieri, F., Ippolito, G., Piacentini, M., Agrati, C., & Fimia, G. M. (2022). Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation. Clinical Proteomics, 19(1), 1–15. https://doi.org/10.1186/s12014-022-09377-7
Chicago
Ciccosanti, Fabiola, Manuela Antonioli, Alessandra Sacchi, Stefania Notari, Anna Farina, Alessia Beccacece, Marisa Fusto, et al. 2022. “Proteomic Analysis Identifies a Signature of Disease Severity in the Plasma of COVID-19 Pneumonia Patients Associated to Neutrophil, Platelet and Complement Activation.” Clinical Proteomics 19 (1): 1–15. doi:10.1186/s12014-022-09377-7.